(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with hu 308 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Arán, VJ; Campillo, NE; Fernández-Ruiz, J; García-Arencibia, M; Girón, R; Gómez-Cañas, M; González-Naranjo, P; Martín, MI; Páez, JA; Pérez, C; Pérez-Macias, N; Sánchez-Robles, E | 1 |
| Campillo, NE; Carrillo-López, N; Girón, R; González-Naranjo, P; Martín-Fontelles, MI; Martín-Vírgala, J; Naves, M; Páez, JA; Pérez, C; Sánchez-Robles, EM | 1 |
| Cheng, J; Duan, W; Hua, T; Li, F; Liu, ZJ; Nie, H; Sun, Y; Wang, H; Wu, M; Xu, Y; Yang, L; Zhang, T; Zhang, Z | 1 |
1 review(s) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and hu 308
| Article | Year |
|---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
3 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and hu 308
| Article | Year |
|---|---|
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cannabinoid Receptor Agonists; Cholinesterase Inhibitors; Computational Biology; Drug Design; Horses; Humans; Indazoles; Ligands; Molecular Docking Simulation; Molecular Structure; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2014 |
New cannabinoid receptor antagonists as pharmacological tool.
Topics: 3T3 Cells; Animals; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Ethers; Indazoles; Mice; Molecular Structure; Receptors, Cannabinoid; Structure-Activity Relationship | 2020 |
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis.
Topics: Animals; Cannabinoids; Carbon; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Multiple Sclerosis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Silicon; Structure-Activity Relationship | 2021 |